Exploring the recent trend in esophageal adenocarcinoma incidence and mortality using comparative simulation modeling

Background: The incidence of esophageal adenocarcinoma (EAC) has increased five-fold in the United States since 1975. The aim of our study was to estimate future U.S. EAC incidence and mortality and to shed light on the potential drivers in the disease process that are conduits for the dramatic incr...

Full description

Bibliographic Details
Main Authors: Kong, C., Kroep, S., Curtius, K., Hazelton, W., Jeon, J., Meza, R., Heberle, C., Miller, M., Choi, S., Lansdorp_Vogelaar, Iris, Van Ballegooijen, M., Feuer, E., Inadomi, J., Hur, C., Luebeck, E.
Format: Journal Article
Published: American Association for Cancer Research Inc 2014
Online Access:http://hdl.handle.net/20.500.11937/50151
_version_ 1848758407072317440
author Kong, C.
Kroep, S.
Curtius, K.
Hazelton, W.
Jeon, J.
Meza, R.
Heberle, C.
Miller, M.
Choi, S.
Lansdorp_Vogelaar, Iris
Van Ballegooijen, M.
Feuer, E.
Inadomi, J.
Hur, C.
Luebeck, E.
author_facet Kong, C.
Kroep, S.
Curtius, K.
Hazelton, W.
Jeon, J.
Meza, R.
Heberle, C.
Miller, M.
Choi, S.
Lansdorp_Vogelaar, Iris
Van Ballegooijen, M.
Feuer, E.
Inadomi, J.
Hur, C.
Luebeck, E.
author_sort Kong, C.
building Curtin Institutional Repository
collection Online Access
description Background: The incidence of esophageal adenocarcinoma (EAC) has increased five-fold in the United States since 1975. The aim of our study was to estimate future U.S. EAC incidence and mortality and to shed light on the potential drivers in the disease process that are conduits for the dramatic increase inEACincidence. Methods: A consortium of three research groups calibrated independent mathematical models to clinical and epidemiologic data includingEACincidence from the Surveillance, Epidemiology, and End Results (SEER 9) registry from 1975 to 2010. We then used a comparative modeling approach to project EAC incidence and mortality to year 2030. Results: Importantly, all three models identified birth cohort trends affecting cancer progression as a major driver of the observed increases in EAC incidence and mortality. All models predict that incidence and mortality rates will continue to increase until 2030 but with a plateauing trend for recent male cohorts. The predicted ranges of incidence and mortality rates (cases per 100,000 person years) in 2030 are 8.4 to 10.1 and 5.4 to 7.4, respectively, for males, and 1.3 to 1.8 and 0.9 to 1.2 for females. Estimates of cumulative cause-specific EAC deaths between both sexes for years 2011 to 2030 range between 142,300 and 186,298, almost double the number of deaths in the past 20 years. Conclusions: Through comparative modeling, the projected increases in EAC cases and deaths represent a critical public health concern that warrants attention from cancer control planners to prepare potential interventions. Impact: Quantifying this burden of disease will aid health policy makers to plan appropriate cancer control measures.
first_indexed 2025-11-14T09:43:30Z
format Journal Article
id curtin-20.500.11937-50151
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T09:43:30Z
publishDate 2014
publisher American Association for Cancer Research Inc
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-501512023-02-22T06:24:18Z Exploring the recent trend in esophageal adenocarcinoma incidence and mortality using comparative simulation modeling Kong, C. Kroep, S. Curtius, K. Hazelton, W. Jeon, J. Meza, R. Heberle, C. Miller, M. Choi, S. Lansdorp_Vogelaar, Iris Van Ballegooijen, M. Feuer, E. Inadomi, J. Hur, C. Luebeck, E. Background: The incidence of esophageal adenocarcinoma (EAC) has increased five-fold in the United States since 1975. The aim of our study was to estimate future U.S. EAC incidence and mortality and to shed light on the potential drivers in the disease process that are conduits for the dramatic increase inEACincidence. Methods: A consortium of three research groups calibrated independent mathematical models to clinical and epidemiologic data includingEACincidence from the Surveillance, Epidemiology, and End Results (SEER 9) registry from 1975 to 2010. We then used a comparative modeling approach to project EAC incidence and mortality to year 2030. Results: Importantly, all three models identified birth cohort trends affecting cancer progression as a major driver of the observed increases in EAC incidence and mortality. All models predict that incidence and mortality rates will continue to increase until 2030 but with a plateauing trend for recent male cohorts. The predicted ranges of incidence and mortality rates (cases per 100,000 person years) in 2030 are 8.4 to 10.1 and 5.4 to 7.4, respectively, for males, and 1.3 to 1.8 and 0.9 to 1.2 for females. Estimates of cumulative cause-specific EAC deaths between both sexes for years 2011 to 2030 range between 142,300 and 186,298, almost double the number of deaths in the past 20 years. Conclusions: Through comparative modeling, the projected increases in EAC cases and deaths represent a critical public health concern that warrants attention from cancer control planners to prepare potential interventions. Impact: Quantifying this burden of disease will aid health policy makers to plan appropriate cancer control measures. 2014 Journal Article http://hdl.handle.net/20.500.11937/50151 10.1158/1055-9965.EPI-13-1233 American Association for Cancer Research Inc unknown
spellingShingle Kong, C.
Kroep, S.
Curtius, K.
Hazelton, W.
Jeon, J.
Meza, R.
Heberle, C.
Miller, M.
Choi, S.
Lansdorp_Vogelaar, Iris
Van Ballegooijen, M.
Feuer, E.
Inadomi, J.
Hur, C.
Luebeck, E.
Exploring the recent trend in esophageal adenocarcinoma incidence and mortality using comparative simulation modeling
title Exploring the recent trend in esophageal adenocarcinoma incidence and mortality using comparative simulation modeling
title_full Exploring the recent trend in esophageal adenocarcinoma incidence and mortality using comparative simulation modeling
title_fullStr Exploring the recent trend in esophageal adenocarcinoma incidence and mortality using comparative simulation modeling
title_full_unstemmed Exploring the recent trend in esophageal adenocarcinoma incidence and mortality using comparative simulation modeling
title_short Exploring the recent trend in esophageal adenocarcinoma incidence and mortality using comparative simulation modeling
title_sort exploring the recent trend in esophageal adenocarcinoma incidence and mortality using comparative simulation modeling
url http://hdl.handle.net/20.500.11937/50151